Search
84 results for “KirstieJane”
-
@KirstieJane whilst people may actually be remote, it's clear that not all work practices have adjusted themselves. We totally do not have #asyncWork working. I think #asyncWork rather than just #remoteFirst is the true goal. Then we each can work/engage when circumstances allow.
-
Tess just talked us through this white paper from #TechUK https://www.techuk.org/resource/techuk-paper-ethics-in-action-from-white-paper-to-workplace.html
-
Really delighted to hear from #Labour MP Chi Onwurah, Chair of the Science, Innovation and Technology Select Committee. She’s speaking on how #OpenSource can deliver #Innovation #ForAll!
Read all about her at https://en.m.wikipedia.org/wiki/Chi_Onwurah
-
I don’t love #ChildrenInNeed #BBCChildrenInNeed for all the reasons that Nina Tame shares on instagram (check out her post at https://www.instagram.com/p/DCUhO4GM39j/, and her website at https://ninatame.komi.io) - in short: children shouldn’t have to share their personal circumstances, difficulties and trauma to be deserving of support and access. That’s what a government should provide.
BUT I do love a nursery bake sale! Look at these amazing #snowman #cupcakes made by Mackenzie’s favourite staff member!
-
https://www.tandfonline.com/doi/full/10.1080/1369118X.2024.2420041
Creative data justice: a decolonial and indigenous framework to assess creativity and artificial intelligence
Payal Arora
-
- Sharing is caring (data, data pipelines, code, results, collaborations)
- Dissemination and impact (papers, impact, policy, communication to the wider public)
- Career paths in healthcare (fellowships, funding, industry, lectureships)Phew!! So many fascinating discussions!
-
As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.
“It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”
-
As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.
“It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”
-
As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.
“It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”
-
As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.
“It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”
-
As part of the discussion Prof Avery has invited Alan Griffiths - who has multiple long term conditions and who takes 14 pills per day. He talks about how these define him (or not) and which elements are the most challenging.
“It’s not the conditions that are the hardest part, it’s what I have to do to manage all of them, every day. Especially through some of the hardest times in my life.”
-
Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.
His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!
-
Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.
His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!
-
Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.
His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!
-
Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.
His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!
-
Our last speaker in this session is Krish Nirantharakumar Co-PI Optimal at the University of Birmingham. His talk is focused on Utilising an informatics consult to improve prescribing.
His team are building tools to visualise and analyse the prescribing of multiple long term conditions. The tool can also start to predict what conditions might emerge over time!
-
@drandrewv2 that’s exactly what our #ExpertsByLivedExperience tell us and others. It’s SO EXHAUSTING to try to navigate the health care system. The most vulnerable fall through the gaps!
I’m so sorry that you had that experience (even if it is so terribly common). Sending big hugs and well done persevering so long! ❤️❤️
-
Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?
The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.
-
Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?
The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.
-
Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?
The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.
-
Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?
The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.
-
Mike Barnes of Queen Mary University is having us ponder even how you define something like a “long term prescription”? What is long? What if someone switches medications? How long a gap is enough to note?
The AI-Multiply team are taking a longitudinal approach and using #AI and data science tools to follow prescribing data over time for individuals and then summarising them across cohorts.
-
Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”
The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.
-
Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”
The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.
-
Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”
The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.
-
Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”
The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.
-
Our next speaker Lauren Walker, Co-PI DynAIRx is presenting on “Using real world data to identify and plan interventions to minimise polypharmacy and transform prescribing in multiple long term conditions”
The team have been engaging with clinicians to ask what AI tools would be useful for them? They all emphasised the importance of transparency in how any tool makes its recommendation / decision.
-
There are multiple dimensions of challenge if you live with #MLTC and we are now turning to a deep dive into one of them: #polypharmacy - taking multiple medications for those multiple conditions.
We’re honoured to have Prof Tony Avery who is the National Clinical Director for Prescribing for NHS England chair the discussion and present an introduction including recommendations for systematic and cultural improvements within the NHS.
-
There are multiple dimensions of challenge if you live with #MLTC and we are now turning to a deep dive into one of them: #polypharmacy - taking multiple medications for those multiple conditions.
We’re honoured to have Prof Tony Avery who is the National Clinical Director for Prescribing for NHS England chair the discussion and present an introduction including recommendations for systematic and cultural improvements within the NHS.
-
There are multiple dimensions of challenge if you live with #MLTC and we are now turning to a deep dive into one of them: #polypharmacy - taking multiple medications for those multiple conditions.
We’re honoured to have Prof Tony Avery who is the National Clinical Director for Prescribing for NHS England chair the discussion and present an introduction including recommendations for systematic and cultural improvements within the NHS.